We are live on
!
Find out more
DFO
Duquesne Family Office Portfolio holdings
AUM
$3.38B
1-Year Est. Return
61.92%
This Fund
S&P 500
This Quarter
Est. Return
+7.24%
1 Year Est. Return
+61.92%
3 Year Est. Return
+280.57%
5 Year Est. Return
+393.65%
10 Year Est. Return
+4,147.23%
AUM
$1.76B
AUM Growth
+$381M
(+28%)
Cap. Flow
+$370M
Cap. Flow
% of AUM
20.99%
Top 10 Holdings %
Top 10 Hldgs %
62.02%
Holding
71
New
28
Increased
11
Reduced
11
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$115M |
| 2 |
Lamb Weston
LW
|
+$74.1M |
| 3 |
Eli Lilly
LLY
|
+$59.5M |
| 4 |
Vertiv
VRT
|
+$55.3M |
| 5 |
Datadog
DDOG
|
+$49.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$145M |
| 2 |
Freeport-McMoran
FCX
|
+$60.4M |
| 3 |
WillScot Mobile Mini Holdings
WSC
|
+$30.8M |
| 4 |
Moderna
MRNA
|
+$28.2M |
| 5 |
Antero Resources
AR
|
+$27.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 25.9% |
| 2 | Technology | 15.31% |
| 3 | Healthcare | 13.85% |
| 4 | Energy | 12.66% |
| 5 | Industrials | 10.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Avantor
AVTR
$9.19B
| $3.72M | 0.21% |
+189,695
| New | +$5.08M |
|
52
IHS Holding
IHS
$2.81B
| $3.44M | 0.2% |
771,096
| – | – |
|
53
10x Genomics
TXG
$6.61B
| $3.32M | 0.19% |
+116,715
| New | +$4.45M |
|
54
SolarEdge
SEDG
$1.95B
| $3.1M | 0.18% |
13,400
| – | – |
|
55
Caribou Biosciences
CRBU
$164M
| $2.86M | 0.16% |
271,430
| – | – |
|
|
56
Moderna
MRNA
$23.6B
| $2.62M | 0.15% |
22,154
-185,526
| -89% | -$28.2M |
|
|
CCC
57
CCC Intelligent Solutions
CCC
$4.08B
| $2.56M | 0.15% |
281,879
| – | – |
|
|
DISH
58
DELISTED
DISH Network Corp.
DISH
| $1.55M | 0.09% |
112,400
| – | – |
|
|
RETA
59
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $1.48M | 0.08% |
58,997
| – | – |
|
60
Acadia Pharmaceuticals
ACAD
$5.03B
| $1.22M | 0.07% |
74,400
| – | – |
|
61
Compass
COMP
$9.66B
| $926K | 0.05% |
399,100
| – | – |
|
62
Peabody Energy
BTU
$2.9B
| $536K | 0.03% |
+21,587
| New | +$485K |
|
|
FTH
63
Faeth Therapeutics
FTH
$629M
| $155K | 0.01% |
5,000
| – | – |
|
|
CZOO
64
DELISTED
Cazoo Group Ltd
CZOO
| $64K | ﹤0.01% |
70
| – | – |
|
65
Joby Aviation
JOBY
$8.55B
| $49K | ﹤0.01% |
+11,246
| New | +$61.7K |
|
66
Booking.com
BKNG
$161B
| – | – |
-193,700
| Closed | -$13.6M |
|
67
Global E Online
GLBE
$7.11B
| – | – |
-20,180
| Closed | -$407K |
|
68
Samsara
IOT
$23.8B
| – | – |
-400,900
| Closed | -$4.48M |
|
69
Procept Biorobotics
PRCT
$1.17B
| – | – |
-39,266
| Closed | -$1.28M |
|
70
Phillips 66
PSX
$81.4B
| – | – |
-119,380
| Closed | -$9.79M |
|
71
Westlake Corp
WLK
$9.9B
| – | – |
-145,520
| Closed | -$14.3M |
|
Similar funds
VFCM
OAM
EFM
BG
DIA
5NCM
MCM
QCG
Duquesne Family Office's Q3 2022 Portfolio in Review
As of Q3 2022, Duquesne Family Office held 71 positions worth $1.76B, up 28% from $1.38B the previous quarter. Its ten largest holdings account for 62% of the portfolio.
Duquesne Family Office deployed $370M of net new capital in Q3 2022, opening 28 new positions and adding to 11 existing holdings. Its largest new stake was Amazon: 906,250 shares worth $102M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 26% of assets, up from 19% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Microsoft, an estimated $145M trimmed.
- Duquesne Family Office's largest Q3 2022 buy was Amazon: 906,250 shares worth $102M.
- Duquesne Family Office added most to Eli Lilly in Q3 2022, an estimated $59.5M increase.
- Duquesne Family Office's biggest Q3 2022 reduction was Microsoft, cutting an estimated $145M.
- Duquesne Family Office fully exited Westlake Corp in Q3 2022, selling an estimated $14.3M.
- Duquesne Family Office's ten largest holdings make up 62% of its $1.76B portfolio in Q3 2022.
- Duquesne Family Office opened 28 new positions and closed 6 in Q3 2022.
- Duquesne Family Office's portfolio value rose 28% quarter-over-quarter to $1.76B.
Based on Duquesne Family Office's 13F filing for Q3 2022, filed 14 Nov 2022.